Related Experiment Video
Updated: Jul 29, 2026

In Vivo Modeling of the Morbid Human Genome using Danio rerio
Published on: August 24, 2013
Connatal Pelizaeus-Merzbacher disease: a missense mutation in exon 4 of the proteolipid protein (PLP) gene
1Department of Pediatrics, National Otaru Hospital, Hokkaido, Japan. CXQ04341@niftyserve.or.jp
Abstract:
We investigated the proteolipid protein (PLP) gene in two brothers in a Japanese family with a connatal form of Pelizaeus-Merzbacher disease (PMD). Direct sequencing of the PLP gene revealed an A-to-T transition in exon 4, which led to an Asp-to-Val substitution at residue 202. Their mother was confirmed to be heterozygous for the mutation. The mutation was not found in 78 X-chromosomes of normal Japanese individuals. A correlation between the clinical severity of the disease in the brothers and the Asp202-to-Val mutation in the PLP gene was suggested.
Insights
Researchers identified a new mutation in the proteolipid protein (PLP) gene in two brothers with Pelizaeus-Merzbacher disease (PMD). This Asp202-to-Val substitution in the PLP gene may correlate with disease severity.
Area of Science:
- Genetics
- Neuroscience
- Molecular Biology
Background:
- Pelizaeus-Merzbacher disease (PMD) is a rare, inherited neurological disorder.
- The proteolipid protein (PLP) gene is crucial for myelin formation in the central nervous system.
Observation:
- Two brothers in a Japanese family presented with a connatal form of Pelizaeus-Merzbacher disease.
- Genetic analysis focused on the proteolipid protein (PLP) gene.
Findings:
- Direct sequencing revealed a specific A-to-T transition in exon 4 of the PLP gene.
- This mutation resulted in an Aspartic acid to Valine substitution at amino acid residue 202 (Asp202-to-Val).
- The mutation was absent in 78 X-chromosomes from healthy Japanese individuals, indicating it is not a common polymorphism.
Implications:
- The identified Asp202-to-Val mutation in the PLP gene is strongly associated with the observed connatal form of PMD.
- A potential correlation between the specific PLP gene mutation and the clinical severity of PMD in the affected brothers is suggested.
- This finding contributes to understanding the genetic basis of PMD and may aid in future diagnostics and genetic counseling.
Related Concept Videos
Mutations
Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
Cytoskeletal Linker Proteins - Plakins
Protein Import into the Peroxisomes
Peroxisomal Protein Import:
Peroxisomes lack the genetic machinery required to code for their own proteins. Hence, most peroxisomal membrane, lumenal and transmembrane proteins are synthesized in the cytoplasm or ER and transported to the peroxisome...
Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life

